Prediction of ADMET properties

ChemMedChem

Volumn 1, Issue 9, 2006, Pages 920-937

  Norinder, Ulf ^a   Bergström, Christel A S ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Absorption; ADMET; In silico; Predictions; Solubility

Indexed keywords

EID: 33749036300     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200600155     Document Type: Review

References (78)

1. "Managing the drug discovery/development interface": T. Kennedy, Drug Discovery Today 1997, 2, 436-444.
2. "Progress in computational methods for the prediction of ADMET properties": D. E. Clark, P. D. Grootenhuis, Curr. Opin. Drug Discovery Dev. 2002, 5, 382-390.
3. "Computational approaches to the understanding of ADMET properties and problems": S. Modi, Drug Discovery Today 2003, 8, 621-623.
4. "ADMET in silico modelling: towards prediction paradise?": H. van de Waterbeemd, E. Gifford, Nat. Rev. Drug Discovery 2003, 2, 192-204.
5. "Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells": P. Artursson, J. Karlsson, Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
6. "Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond": P. Artursson, R. T. Borchardt, Pharm. Res. 1997, 14, 1655-1658.
7. "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings": C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeny, Adv. Drug Delivery Rev. 1997, 23, 3-25.
8. "Can the pharmaceutical industry reduce attrition rates?": I. Kola, J. Landis, Nat. Rev. Drug Discovery 2004, 3, 711-716.
9. "Drug-like properties and the causes of poor solubility and poor permeability": C. A. Lipinski, J. Pharmacol. Toxicol. Methods 2000, 44, 235-249.
10. "Molecular descriptors influencing melting point and their role in classification of solid drugs": C. A. S. Bergström, U. Norinder, K. Luthman, P. Artursson, J. Chem. Inf. Comput. Sci. 2003, 43, 1177-1185.
11. "Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat": J. R. Pappenheimer, K. Z. Reiss, J. Membr. Biol. 1987, 100, 123-136.
12. "Quantitative structure-activity relationships (QSARs) in toxicology: a historical perspective": T. W. Schultz, M. T. D. Cronin, J. D. Walker, A. O. Aptula, J. Mol. Struct. 2003, 622, 1-22.
13. "Physicochemical high-throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes": M. Kansy, F. Senner, K. Gubernator, J. Med. Chem. 1998, 41, 1007-1010.
14. "Pitfalls in QSAR": T. W. Schultz, M. T. D. Cronin, J. Mol. Struct. 2003, 622, 39-51.
15. "The rate of solution of solid substances in their own solutions": A. A. Noyes, W. R. Whitney, J. Am. Chem. Soc. 1897, 19, 930-934.
16. "The calculation of the hydrogen number of the blood from the free and bound carbon dioxide of the same and the binding of oxygen by the blood as a function of the hydrogen number": K. A. Hasselbalch, Biochem. Z. 1916, 78, 112-144.
17. "Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals": T. T. Kararli, Biopharm. Drug Dispos. 1995, 16, 351-380.
18. "Common ion equilibriums of hydrochloride salts and the Setschenow equation": J. B. Bogardus, J. Pharm. Sci. 1982, 71, 588-590.
19. "Aqueous solubility of diclofenac diethylamine in the presence of pharmaceutical additives: a comparative study with diclofenac sodium": E. Khalil, S. Najjar, A. Sallam, Drug Dev. Ind. Pharm. 2000, 26, 375-381.
20. "Mechanism of protein salting in and salting out by divalent cation salts: balance between hydration and salt binding": T. Arakawa, S. N. Timasheff, Biochemistry 1984, 23, 5912-5923.
21. "Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH": W. N. Charman, C. J. Porter, S. Mithani, J. B. Dressman, J. Pharm. Sci. 1997, 86, 269-282.
22. "Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability": I. J. Hidalgo, T. J. Raub, R. T. Borchardt, Gastroenterology 1989, 96, 736-749.
23. "Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells": P. Artursson, J. Pharm. Sci. 1990, 79, 476-482.
24. "MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening": J. D. Irvine, L. Takahashi, K. Lockhart, J. Cheong, J. W. Tolan, H. E. Selick, J. R. Grove, J. Pharm. Sci. 1999, 88, 28-33.
25. "A conditionally immortalized epithelial cell line for studies of intestinal drug transport": S. Tavelin, V. Milovic, G. Ocklind, S. Olsson, P. Artursson, J. Phormacol. Exp. Ther. 1999, 290, 1212-1221.
26. "Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man": H. Lennernäs, Ö. Ahrenstedt, R. Hällgren, L. Knutson, M. Ryde, L. Paalzow, Pharm. Res. 1992, 9, 1243-1251.
27. "Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors": Y. H. Zhao, J. Le, M. H. Abraham, A. Mersey, P. J. Eddershaw, C. N. Luscombe, D. Boutina, G. Beck, B. Sherborne, I. Cooper, J. A. Platts, J. Pharm. Sci. 2001, 90, 749-784.
28. "ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans": G. Klopman, L. R. Stefan, R. D. Saiakhov, Eur. J. Pharm. Sci. 2002, 17, 253-263.
29. "Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures": T. Niwa, J. Chem. Inf. Comput. Sci. 2003, 43, 113-119.
30. "A topological sub-structural approach for predicting human intestinal absorption of drugs": M. A. Perez, M. B. Sanz, L. R. Torres, R. G. Avalos, M. P. Gonzalez, H. G. Diaz, Eur. J. Med Chem. 2004, 39, 905-916.
31. "Estimation of aqueous solubility for a diverse set of organic com-pounds based on molecular topology": J. Huuskonen, J. Chem. Inf. Comput. Sci. 2000, 40, 773-777.
32. "Prediction of drug solubility from structure": W. L. Jorgensen, E. M. Duffy, Adv. Drug Delivery Rev. 2002, 54, 355-366.
33. "A consensus neural network-based technique for discriminating soluble and poorly soluble compounds": D.T. Manallack, B. G. Tehan, E. Gancia, B. D. Hudson, M. G. Ford, D. J. Livingstone, D. C. Whitley, W. R. Pitt, J. Chem. Inf. Comput. Sci. 2003, 43, 674-679.
34. "Prediction of aqueous solubility using rule-based systems": U. Norinder, P. Lidén, H. Boström, (RDS, www.compumine.com) and ensemble modeling, unpublished results.
35. "Simulation of water transport through a lipid membrane": S. J. Marrink, H. J. C. Berendsen, J. Phys. Chem. 1994, 98, 4155-4168.
36. "The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability": R. A. Conradi, A. R. Hilgers, N. F. Ho, P. S. Burton, Pharm. Res. 1992, 9, 435-439.
37. "Polar molecular surface properties predict the intestinal absorption of drugs in humans": K. Palm, P. Stenberg, K. Luthman, P. Artursson, Pharm. Res. 1997, 14, 568-571.
38. "Predicting drug absorption from molecular surface properties based on molecular dynamics simulations": L. Hjorth Krarup, I. Thoger Christensen, L. Hovgaard, S. Frokjaer, Pharm. Res. 1998, 15, 972-978.
39. "Evaluation of dynamic polar molecular surface area as predictor of drug absorption: Comparison with other computational and experimental predictors": K. Palm, K. Luthman, A. L. Ungell, G. Strandlund, F. Beigi, P. Lundahl, P. Artursson, J. Med. Chem. 1998, 41, 5382-5392.
40. "Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight": G. Camenisch, J. Alsenz, H. van de Waterbeemd, G. Folkers, Eur. J. Pharm. Sci. 1998, 6, 313-319.
41. "Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties": P. Stenberg, K. Luthman, P. Artursson, Pharm. Res. 1999, 16, 205-212.
42. "Experimental and computational screening models for the prediction of intestinal drug absorption": P. Stenberg, U. Norinder, K. Luthman, P. Artursson, J. Med. Chem. 2001, 44, 1927-1937.
43. "Molecular properties that influence the oral bioavailability of drug candidates": D. F. Veber, S. R. Johnson, H. Y. Cheng, B. R. Smith, K. W. Ward, K. D. Kopple, J. Med. Chem. 2002, 45, 2615-2623.
44. "Solubility properties in biological media 9: prediction of solubility and partition of organic nonelectrolytes in blood and tissues from solvatochromic parameters": M. J. Kamlet, R. M. Doherty, V. Fiserova-Bergerova, P. W. Carr, M. H. Abraham, R. W. Taft, J. Pharm. Sci. 1987, 76, 14-17.
45. "Molecular factors influencing drug transfer across the blood-brain barrier": J. A. Gratton, M. H. Abraham, M. W. Bradbury, H. S. Chadha, J. Pharm. Pharmacol. 1997, 49, 1211-1216.
46. "On the mechanism of human intestinal absorption": M. H. Abraham, Y. H. Zhao, J. Le, A. Hersey, C. N. Luscombe, D. P. Reynolds, G. Beck, B. Sherborne, I. Cooper, Eur. J. Med. Chem. 2002, 37, 595-605.
47. "SLIPPER-2001-Software for predicting molecular properties on the basis of physicochemical descriptors and structural similarity": O. A. Raevsky, S. V. Trepalin, H. P. Trepalina, V. A. Gerasimenko, O. E. Raevskaja, J. Chem. Inf. Comput. Sci. 2002, 42, 540-549.
48. "Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parameterization and PLS statistics": U. Norinder, T. Österberg, P. Artursson, Pharm. Res. 1997, 14, 1786-1791.
49. "Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parameterization and PLS statistics": U. Norinder, T. Österberg, P. Artursson, Eur. J. Pharm. Sci. 1999, 8, 49-56.
50. "Prediction of human intestinal absorption of drug compounds from molecular structure": M. D. Wessel, P. C. Jurs, J. W. Tolan, S. M. Muskal, J. Chem. Inf. Comput. Sci. 1998, 38, 726-735.
51. "A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability": G. L. Amidon, H. Lennernäs, V. P. Shah, J. R. Crison, J. Pharm. Res. 1995, 12, 413-420.
52. "HT29-MTX/Caco-2 co-cultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans": E. Walter, S. Janich, B. J. Roessler, J. M. Hilfinger, G. L. J. Amidon, Pharm. Sci. 1996, 85, 1070-1076.
53. "Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach": S. Winiwarter, N. M. Bonham, F. Ax, A. Hallberg, H. Lennernàs, A. Karlén, J. Med. Chem. 1998, 41, 4939-4949.
54. "Molecular properties of WHO essential drugs and provisional biopharmaceutical classification": N. A. Kasim, M. Whitehouse, C. Ramachandran, M. Bermejo, H. Lennernäs, A. S. Hussain, H. E. Junginger, S. A. Stavchansky, K. K. Midha, V. P. Shah, G. L. Amidon, Mol. Pharm. 2004, 1, 85-96.
55. "Absorption classification of oral drugs based on molecular surface properties": C. A. S. Bergström, M. Strafford, L. Lazorova, A. Avdeef, K. Luthman, P. Artursson, J. Med. Chem. 2003, 46, 558-570.
56. "Computer systems for the prediction of toxicity: An update": N. Green, Adv. Drug Delivery Rev. 2002, 54, 417-431.
57. "The present status of QSAR in toxicology": T. W. Schultz, M. T. D. Cronin, T. I. Netzeva, J. Mol. Struct. 2003, 622, 23-38.
58. "In silico prediction of drug toxicity": J. C. Dearden, J. Comput.-Aided Mol. Des. 2003, 17, 119-127.
59. "Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism": D. F. V. Lewis, S. Modi, M. Dickins, Drug Metab. Drug Interact. 2001, 18, 221-242.
60. "QSAR of cytochromes P450": C. Hansch, S. B. Mekapati, A. Karup, R. P. Verma, Drug Metab. Rev. 2004, 36, 105-156.
61. "In silico modelling of ADMET-a minireview of work 2000 to 2004": U. Norinder, SAR QSAR Environ. Res. 2005, 76, 1-11.
62. "In silico ADME/Tox: why models fail": T. R. Stouch, J. R. Kenyon, S. R. Johnson, X.-Q. Chen, A. Doweyko, Y. Li, J. Comput.-Aided Mol. Des. 2003, 17, 83-92.
63. "Predictive toxicology: benchmarking molecular descriptors and statistical methods": J. Feng, L. Lurati, H. Ouyang, T. Robinson, Y. Wang, S. Yuan, S. S. Young, J. Chem. Inf. Comput. Sci. 2003, 43, 1463-1470.
64. "Prediction of aqueous solubility of organic compounds based on a 3D structure representation": A. Yan, J. Gasteiger, J. Chem. Inf. Comput. Sci. 2003, 43, 429-434.
65. "Development of quantitative structure-property relationship models for early ADME evaluation in drug discovery. 1. Aqueous solubility": R. Liu S.-S. So, J. Chem. Inf. Comput. Sci. 2001, 41, 1633-1639.
66. "Estimation of aqueous solubility of chemical compounds using e-state indices": I. V. Tetko, V. Yu. Tanchuk, T. N. Kasheva, A. E. P. Villa, J. Chem. Inf. Comput. Sci. 2001, 41, 1488-1493.
67. "Prediction of aqueous solubility and partition coefficient optimized by a genetic algorithm based descriptor selection method": J. K. Wegner, A. Zell, J. Chem. Inf. Comput. Sci. 2003, 43, 1077-1084.
68. "Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties": P. Ertl, B. Rohde, P. Selzer, J. Med. Chem. 2000, 43, 3714-3717.
69. "Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis": A. Kulkarni, Y. Han, A. J. Hopfinger, J. Chem. Inf. Comput. Sci. 2002, 42, 331-342.
70. "ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties": T. J. Hou, W. Zhang, K. Xia, X. B. Qiao, X. J. Xu, J. Chem. Inf. Comput. Sci. 2004, 44, 1585-1600.
71. "A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell cluture": P. Y. Marrero, P. M. A. Cabrera, Z. V. Romero, D. H. Gonzalez, F. Torrens, J. Pharm. Pharm. Sci. 2004, 7, 186-199.
72. "Toward minimalistic modeling of oral drug absorption": T. I. Oprea, J. Gottfries, J. Mol. Graph. Model. 1999, 17, 261-274.
73. "Prediction of polar surface area and drug transport processes using simple parameters and PLS statistics": T. Österberg, U. Norinder, J. Chem. Inf. Comput. Sci. 2000, 40, 1408-1411.
74. "Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors": T. Österberg, U. Norinder, Eur. J. Pharm. Sci. 2001, 12, 327-337.
75. "Theoretical calculation and prediction of drug transport processes using simple parameters and partial least squares projections to latent structures (PLS) statistics. The use of electrotopological state indices": U. Norinder, T. Österberg, J. Pharm. Sci. 2001, 90, 1076-1085.
76. "Exploring the role of different drug transport routes in permeability screening": P. Matsson, C. A. S. Bergström, N. Nagahara, S. Tavelin, U. Norinder, P. Artursson, J. Med. Chem. 2005, 48, 604-613.
77. "Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network": S. Fujiwara, F. Yamashita, M. Hashida, Int. J. Pharm. 2002, 237, 95-105.
78. "Two- and three-dimensional QSAR of carrier-mediated transport of β-lactam antibiotics in Caco-2 cells": S. Wanchana, F. Yamashita, H. Hara, S. Fujiwara, M. Akamatsu, M. Hashida, J. Pharm. Sci. 2004, 93, 3057-3065.